RG
Replimune Group Inc
🇺🇸XNAS.REPLUnited StatesHealthcare
$12.96USDdown -0.09 (-0.69%)OpenDelayed3:09 PM
Price$12.96-0.09 (-0.69%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US76029N1063
- CUSIP
- 76029N106
Company
- Employees
- 465
- Headquarters
- Woburn, United States
- Website
- https://www.replimune.com
- CEO
- Dr. Sushil Patel Ph.D.
Market
- Shares outstanding
- 94.2M
- Market cap
- $1.22B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.21B
- EPS LTM
- -$3.07
- P/E LTM
- -3.70
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$297.01M-5.99%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$280.55M-23.12%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.